PARACRINE REGULATION OF ADIPOSE DIFFERENTIATION BY ARACHIDONATE METABOLITES - PROSTAGLANDIN-F(2-ALPHA) INHIBITS EARLY AND LATE MARKERS OF DIFFERENTIATION IN THE ADIPOGENIC CELL LINE-1246

The effect of arachidonate metabolites on the differentiation of the adipogenic cell line 1246 was investigated. Among the metabolites examined, only prostaglandin F2alpha (PGF2alpha) inhibited differentiation in a dose-dependent fashion with an ED50 of 3 X 10(-9) M. PGF2alpha inhibited the mRNA expression of lipoprotein lipase, clone 154, and fatty acid-binding protein, which are early markers of differentiation, as well as glycerol-3-phosphate dehydrogenase specific activity and triglyceride accumulation, which are late markers of differentiation. Chronic exposure of 1246 cells to PGF2alpha before and during differentiation indicated that the cells that have just initiated their differentiation program were the most susceptible to the inhibitory effect of PGF2alpha. Since 1246 cells produce PGs, we determined whether the PG produced by the cells influenced adipose differentiation. Cyclooxygenase inhibitors added to the culture medium stimulated differentiation of 1246 cells up to 18-fold depending on the type and concentration of inhibitor used. In contrast, lipoxygenase inhibitors had no effect. Treatment of 1246 cells with arachidonic acid resulted in a dose-dependent inhibition of cell differentiation. Oleate or linoleate had no effect. These data indicate that PGF2alpha inhibits early and late events of adipose differentiation and that the endogenous production of PGs (particularly PGF2alpha) plays an important role as a negative paracrine or autocrine regulatory pathway of adipose differentiation.